| 标题 |
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial |
| 网址 | |
| DOI |
10.1016/s1470-2045(21)00693-8
doi
|
| 其它 |
期刊:Lancet Oncology 作者:David Cella; Robert J. Motzer; Cristina Suárez; Steven I. Blum; Flavia Ejzykowicz; et al 出版日期:2022-01-12 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)